IRF6 and cancer: We were further able to confirm cancer cell-specific IRF6 protein downregulation by immunoblotting (Figure 2B) and IF staining (Figure 2C) in all those cancer types we had normal control cells available (i.e., lung, breast, skin, and oral cavity).